Technology that maximizes treatment effectiveness of
cancer/inflammatory drugs by removing NO
Control cancer microimmune environment
Immuno-cancer drug combinations
(Immune Gate Inhibitors, CAR T/NK/NKT cell therapy medicine, etc.) : OM-202-SC
Controlling the inflammatory immune environment
Medicines used for inflammatory diseases : OM-202-SM
Rheumatoid arthritis first-in-class medication : OM-201-RA
Treatment for colorectal cancer and inflammatory bowel disease : OM-202-IBD